Discover investment opportunities in Most Undervalued Dividend Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Most Undervalued Dividend Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Most Undervalued Dividend Stocks using our Smart AI Filter.
10 stocks found for "Most Undervalued Dividend Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.23 | ±21.9% | 9.2 | 6.32% | |||
0.45 | ±25.0% | 14.4 | 3.19% | |||
1.42 | ±68.1% | 7.8 | 8.68% | |||
1.06 | ±59.4% | 23.2 | 0.00% | |||
0.80 | ±23.1% | 7.4 | 4.97% | |||
0.21 | ±19.0% | 11.1 | 6.84% | |||
0.32 | ±24.8% | 8.7 | 6.75% | |||
0.31 | ±23.4% | 12.7 | 3.92% | |||
0.77 | ±40.2% | 10.4 | 3.94% | |||
1.15 | ±36.7% | 21.2 | 0.66% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How can an investor determine if "MO" offers a good dividend yield?
A: Investors can assess MO’s dividend yield by comparing its dividends per share to its market price. Looking at payout ratios and historical dividend sustainability is crucial, as these provide insights into future dividend reliability. As of the last update, MO had a relatively high yield, but it's important to consider its industry risks and historical performance.
Q: What are the risks associated with AT&T's ("T") dividend payments?
A: The primary risks include AT&T's substantial debt and the competitive pressures in the telecom industry, which could potentially impact its cash flow and ability to maintain dividends. Investors should monitor its financial health, as large debt loads can strain dividend sustainability, especially amidst market volatility.
Q: Why might "INTC" be considered an appealing investment option for tech sector exposure?
A: Intel ("INTC") offers exposure to the semiconductor industry, benefiting from its strong market position and consistent demand for chips. Despite recent industry challenges, its history of innovation and established customer base may appeal to investors seeking growth potential within tech.
Q: What sector-specific factors might influence Chevron's ("CVX") stock performance?
A: Chevron's performance is heavily tied to oil price fluctuations, regulatory environments, and global energy demand. As an oil giant, its profitability can vary with energy market cycles, making it crucial for investors to track sector trends and economic conditions impacting oil prices.
Q: Is "ABBV" suitable for stability-focused investors?
A: Some consider ABBV suitable for stability due to its strong pharmaceutical portfolio and consistent revenue from blockbuster drugs. However, patent expirations pose risks, so it's important for investors to analyze pipeline prospects and competitive pressures.
Q: What historical data points should be considered when evaluating Pfizer's ("PFE") dividend consistency?
A: Investors should review past dividend payout ratios, earnings consistency, and cash flow stability. Pfizer's track record of maintaining dividends even during challenging periods may indicate reliability, but patent cliffs and industry competition require consideration.
Amgen said it will spend more than $600 million to build a new research and development facility at its headquarters in Thousand Oaks, California. It is the latest in a string of new U.S. investments by the pharmaceutical industry as President Donald Trump threatens to clamp down on the industry with tariffs on pharmaceuticals imported into the country.
Read moreIn late August, the U.S. government agreed to take roughly a 10 percent equity stake in Intel, converting about $8.9 billion of previously committed CHIPS and Secure Enclave funds into shares. This is an unprecedented move that effectively swaps subsidies for ownership.
Read moreThe brokerage service is replacing Walgreens Boots Alliance, which is being taken private in a deal with Sycamore Partners that is expected to close soon. Interactive Brokers shares jumped nearly 5% in after-hours trading on the news.
Read more